Funding Details
- Awarder
- Inbox
- Date Award
- February 16, 2016
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
Company Info
- Founders
- Raju Mohan, PhD
- Company Description
- Akarna Therapeutics is a privately held biopharmaceutical company developing novel small molecule therapeutics that target inflammatory and fibrotic diseases for which there is no approved treatment. Akarna's lead program is a potential best-in-class FXR agonist for the treatment of non-alcoholic steatohepatitis (NASH). Akarna's lead candidate is currently in preclinical, IND-enabling toxicology and safety pharmacology studies.
- Market
- Inflammatory and fibrotic diseases
- Location
-
Encinitas,
CA,
USA
- Coinvestors
- Forbion Capital Partners, New Science Ventures, Third Point Ventures
Links